As the US Chronic Kidney Disease Market continues to expand, healthcare providers are increasingly adopting integrated care models to manage the complexities of this condition. The shift from reactive treatment to proactive, evidence-based management is transforming the pharmaceutical and medical device sectors. Factors such as a growing diabetic population—a primary contributor to...